相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。CD8+ T cells promote HIV latency by remodeling CD4+ T cell metabolism to enhance their survival , quiescence, and stemness
Simona Mutascio et al.
IMMUNITY (2023)
HIV post-treatment controllers have distinct immunological and virological features
Behzad Etemad et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)
Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses
Kevin B. Einkauf et al.
CELL (2022)
Combination Immune Checkpoint Blockade Enhances IL-2 and CD107a Production from HIV-Specific T Cells Ex Vivo in People Living with HIV on Antiretroviral Therapy
Chris Y. Chiu et al.
JOURNAL OF IMMUNOLOGY (2022)
Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial
Jeffrey S. Miller et al.
NATURE MEDICINE (2022)
CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection
Mary S. Pampusch et al.
PLOS PATHOGENS (2022)
Immune checkpoint blockade in HIV
Celine Gubser et al.
EBIOMEDICINE (2022)
Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers
Luis M. Molinos-Albert et al.
NATURE COMMUNICATIONS (2022)
Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and Cancer
Marine Baron et al.
CELLS (2022)
Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaques
John D. Ventura et al.
NPJ VACCINES (2022)
Myeloid cell tropism enables MHC-E-restricted CD8+ T cell priming and vaccine efficacy by the RhCMV/SIV vaccine
Scott G. Hansen et al.
SCIENCE IMMUNOLOGY (2022)
The role of latency reversal in HIV cure strategies
Kiho Tanaka et al.
JOURNAL OF MEDICAL PRIMATOLOGY (2022)
Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8+ T cells
Hiroshi Takata et al.
EBIOMEDICINE (2022)
Reprogramming dysfunctional CD8+ T cells to promote properties associated with natural HIV control
Federico Perdomo-Celis et al.
JOURNAL OF CLINICAL INVESTIGATION (2022)
Immune Checkpoint Inhibitors in Cancer Therapy
Yavar Shiravand et al.
CURRENT ONCOLOGY (2022)
Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremia
Yoshiaki Nishimura et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
MEK inhibition reprograms CD8+ T lymphocytes into memory stem cells with potent antitumor effects
Vivek Verma et al.
NATURE IMMUNOLOGY (2021)
Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption
Marcos V. P. Gondim et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Multi-stakeholder consensus on a target product profile for an HIV cure
Sharon R. Lewin et al.
LANCET HIV (2021)
Prolonged Posttreatment Virologic Control and Complete Seroreversion After Advanced Human Immunodeficiency Virus-1 Infection
Analia Uruena et al.
OPEN FORUM INFECTIOUS DISEASES (2021)
TCF-1 regulates HIV-specific CD8+ T cell expansion capacity
Rachel L. Rutishauser et al.
JCI INSIGHT (2021)
Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy
Jana Blazkova et al.
NATURE MEDICINE (2021)
Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021
Steven G. Deeks et al.
NATURE MEDICINE (2021)
CD8 Lymphocyte Depletion Enhances the Latency Reversal Activity of the SMAC Mimetic AZD5582 in ART-Suppressed Simian Immunodeficiency Virus-Infected Rhesus Macaques
Maud Mavigner et al.
JOURNAL OF VIROLOGY (2021)
The impact of immune checkpoint therapy on the latent reservoir in HIV-infected individuals with cancer on antiretroviral therapy
Jillian S. Y. Lau et al.
AIDS (2021)
Suspected Immune-Related Adverse Events With an Anti-PD-1 Inhibitor in Otherwise Healthy People With HIV
Cynthia L. Gay et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2021)
CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification
Afam A. Okoye et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Epigenetic Mechanisms of HIV-1 Persistence
Roxane Verdikt et al.
VACCINES (2021)
Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity
Yugang Guo et al.
NATURE IMMUNOLOGY (2021)
The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy
Devi SenGupta et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
PD-1 blockade and vaccination provide therapeutic benefit against SIV by inducing broad and functional CD8+ T cells in lymphoid tissue
Sheikh Abdul Rahman et al.
SCIENCE IMMUNOLOGY (2021)
Broadly neutralizing antibody derived CAR T cells reduce viral reservoir in individuals infected with HIV-1
Bingfeng Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
How elite controllers and posttreatment controllers inform our search for an HIV-1 cure
Jonathan Z. Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
T cell-based strategies for HIV-1 vaccines
Bette Korber et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells
Julia Bergild McBrien et al.
NATURE (2020)
Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity
Julia Niessl et al.
NATURE MEDICINE (2020)
The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies
Lillian B. Cohn et al.
CELL HOST & MICROBE (2020)
The Determination of HIV-1 RT Mutation Rate, Its Possible Allosteric Effects, and Its Implications on Drug Resistance
Joshua Yi Yeo et al.
VIRUSES-BASEL (2020)
The human IL-15 superagonist N-803 promotes migration of virus-specific CD8+ T and NK cells to B cell follicles but does not reverse latency in ART-suppressed, SHIV-infected macaques
Gabriela M. Webb et al.
PLoS Pathogens (2020)
Advances in Developing CAR T-Cell Therapy for HIV Cure
Jinxin Qi et al.
FRONTIERS IN IMMUNOLOGY (2020)
TOX is expressed by exhausted and polyfunctional human effector memory CD8+ T cells
Takuya Sekine et al.
SCIENCE IMMUNOLOGY (2020)
Canonical Wnts Mediate CD8+ T Cell Noncytolytic Anti-HIV-1 Activity and Correlate with HIV-1 Clinical Status
Jennillee Wallace et al.
JOURNAL OF IMMUNOLOGY (2020)
Optimal Maturation of the SIV-Specific CD8+ T Cell Response after Primary Infection Is Associated with Natural Control of SIV: ANRS SIC Study
Caroline Passaes et al.
CELL REPORTS (2020)
Innate, non-cytolytic CD8+T cell-mediated suppression of HIV replication by MHC-independent inhibition of virus transcription
Michelle Zanoni et al.
PLOS PATHOGENS (2020)
Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1
Lynn N. Bertagnolli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
CD8+ T cells in HIV control, cure and prevention
David R. Collins et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Safety and Efficacy of Immune Checkpoint Inhibitor Therapy in Patients With HIV Infection and Advanced-Stage Cancer A Systematic Review
Michael R. Cook et al.
JAMA ONCOLOGY (2019)
CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
Laura M. McLane et al.
Annual Review of Immunology (2019)
The γc Family of Cytokines: Basic Biology to Therapeutic Ramifications
Warren J. Leonard et al.
IMMUNITY (2019)
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
Filipe Martins et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
VACCINOLOGY Structural topology defines protective CD8+ T cell epitopes in the HIV proteome
Gaurav D. Gaiha et al.
SCIENCE (2019)
Induction of Follicular-Like CXCR5+ CD8+ T Cells by TGF-β1/IL-23 Is Limited During HIV Infection
Federico Perdomo-Celis et al.
VIRAL IMMUNOLOGY (2019)
CTL-mediated immunotherapy can suppress SHIV rebound in ART-free macaques
Jin Fan et al.
NATURE COMMUNICATIONS (2019)
CD8+ T-Cell Response to HIV Infection in the Era of Antiretroviral Therapy
Federico Perdomo-Celis et al.
FRONTIERS IN IMMUNOLOGY (2019)
Attacking Latent HIV with convertibleCAR-T Cells, a Highly Adaptable Killing Platform
Eytan Herzig et al.
CELL (2019)
Why and where an HIV cure is needed and how it might be achieved
Thumbi Ndung'u et al.
NATURE (2019)
Metabolic plasticity of HIV-specific CD8+ T cells is associated with enhanced antiviral potential and natural control of HIV-1 infection
Mathieu Angin et al.
NATURE METABOLISM (2019)
The STING ligand cGAMP potentiates the efficacy of vaccine-induced CD8+ T cells
Alice Gutjahr et al.
JCI INSIGHT (2019)
ALT-803 Transiently Reduces Simian Immunodeficiency Virus Replication in the Absence of Antiretroviral Treatment
Amy L. Ellis-Connell et al.
JOURNAL OF VIROLOGY (2018)
Getting the Kill into Shock and Kill: Strategies to Eliminate Latent HIV
Youry Kim et al.
CELL HOST & MICROBE (2018)
Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells
Szu-Han Huang et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
AIDS malignancy consortium (AMC) 095: A phase I study of ipilimumab (IPI) and nivolumab (NIVO) in advanced HIV-associated solid tumors (ST) with expansion cohorts in HIV-associated solid tumors and classical Hodgkin lymphoma (cHL).
Lakshmi Rajdev et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
An open-label, multiple ascending dose study of the anti-CTLA-4 antibody ipilimumab in viremic HIV patients
Elizabeth Colston et al.
PLOS ONE (2018)
Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cell Engineered to Target B Cell Follicles and Suppress SIV Replication
Kumudhini Preethi Haran et al.
FRONTIERS IN IMMUNOLOGY (2018)
HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers
Radwa Sharaf et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
The Control of HIV after Antiretroviral Medication Pause (CHAMP) study: post-treatment controllers identified from 14 clinical studies
Golnaz Namazi et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys
Erica N. Borducchi et al.
NATURE (2018)
Antioxidant metabolism regulates CD8+ T memory stem cell formation and antitumor immunity
Karolina Pilipow et al.
JCI INSIGHT (2018)
CAR T cells for infection, autoimmunity and allotransplantation
Colby R. Maldini et al.
NATURE REVIEWS IMMUNOLOGY (2018)
The human IL-15 superagonist ALT-803 directs SIV-specific CD8(+) T cells into B-cell follicles
Gabriela M. Webb et al.
BLOOD ADVANCES (2018)
Heterodimeric IL15 Treatment Enhances Tumor Infiltration, Persistence, and Effector Functions of Adoptively Transferred Tumor-specific T Cells in the Absence of Lymphodepletion
Sinnie Sin Man Ng et al.
CLINICAL CANCER RESEARCH (2017)
Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy
Cynthia L. Gay et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy
Angela Tsai et al.
JOURNAL OF VIROLOGY (2017)
Early antibody therapy can induce long-lasting immunity to SHIV
Yoshiaki Nishimura et al.
NATURE (2017)
Defining total-body AIDS-virus burden with implications for curative strategies
Jacob D. Estes et al.
NATURE MEDICINE (2017)
Natural killer cells migrate into and control simian immunodeficiency virus replication in lymph node follicles in African green monkeys
Nicolas Huot et al.
NATURE MEDICINE (2017)
Delayed differentiation of potent effector CD8+ T cells reducing viremia and reservoir seeding in acute HIV infection
Hiroshi Takata et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor
Rachel S. Leibman et al.
PLOS PATHOGENS (2017)
Impairment of the type I interferon response by HIV-1: Potential targets for HIV eradication
Teslin S. Sandstrom et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2017)
Interleukin 17 is a chief orchestrator of immunity
Marc Veldhoen
NATURE IMMUNOLOGY (2017)
CD8+ Lymphocytes Are Required for Maintaining Viral Suppression in SIV-Infected Macaques Treated with Short-Term Antiretroviral Therapy
Emily K. Cartwright et al.
IMMUNITY (2016)
The host STING pathway at the interface of cancer and immunity
Leticia Corrales et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
The CD8+cell non-cytotoxic antiviral response affects RNA polymerase II-mediated human immunodeficiency virus transcription in infected CD4+cells
Dalibor Blazek et al.
JOURNAL OF GENERAL VIROLOGY (2016)
Killer lymphocytes use granulysin, perforin and granzymes to kill intracellular parasites
Farokh Dotiwala et al.
NATURE MEDICINE (2016)
Broadly targeted CD8+ T cell responses restricted by major histocompatibility complex E
Scott G. Hansen et al.
SCIENCE (2016)
Triggering Intracellular Receotors for Vaccine Acjuvantation
Alice Gutjahr et al.
TRENDS IN IMMUNOLOGY (2016)
HIV-1 Reservoirs During Suppressive Therapy
Kirston Barton et al.
TRENDS IN MICROBIOLOGY (2016)
Therapeutic vaccines and immunological intervention in HIV infection: a paradigm change
Giuseppe Pantaleo et al.
CURRENT OPINION IN HIV AND AIDS (2016)
Designing optimal HIV-vaccine T-cell responses
Hendrik Streeck
CURRENT OPINION IN HIV AND AIDS (2016)
Immune activation during acute HIV infection and the impact of early antiretroviral therapy
Shelly J. Krebs et al.
CURRENT OPINION IN HIV AND AIDS (2016)
A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes
R. Brad Jones et al.
PLOS PATHOGENS (2016)
HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report
Pierre Frange et al.
LANCET HIV (2016)
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015
Haidong Wang et al.
LANCET HIV (2016)
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations
Kai Deng et al.
NATURE (2015)
B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers
Yoshinori Fukazawa et al.
NATURE MEDICINE (2015)
Elite control of HIV: is this the right model for a functional cure?
Leslie R. Cockerham et al.
TRENDS IN MICROBIOLOGY (2015)
Dyslipidemia and Cardiovascular Risk in Human Immunodeficiency Virus Infection
Theodoros Kelesidis et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2014)
Vaccine-elicited Human T Cells Recognizing Conserved Protein Regions Inhibit HIV-1
Nicola Borthwick et al.
MOLECULAR THERAPY (2014)
Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys
James B. Whitney et al.
NATURE (2014)
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
Gerald P. Linette et al.
BLOOD (2013)
Efficacy and Mechanism-of-Action of a Novel Superagonist Interleukin-15: Interleukin-15 Receptor αSu/Fc Fusion Complex in Syngeneic Murine Models of Multiple Myeloma
Wenxin Xu et al.
CANCER RESEARCH (2013)
HIV-associated chronic immune activation
Mirko Paiardini et al.
IMMUNOLOGICAL REVIEWS (2013)
HIV controllers: a genetically determined or inducible phenotype?
Asier Saez-Cirion et al.
IMMUNOLOGICAL REVIEWS (2013)
Immune clearance of highly pathogenic SIV infection
Scott G. Hansen et al.
NATURE (2013)
Cytomegalovirus Vectors Violate CD8+ T Cell Epitope Recognition Paradigms
Scott G. Hansen et al.
SCIENCE (2013)
Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
Asier Saez-Cirion et al.
PLOS PATHOGENS (2013)
New Paradigms for HIV/AIDS Vaccine Development
Louis J. Picker et al.
ANNUAL REVIEW OF MEDICINE, VOL 63 (2012)
APOBEC3G-Induced Hypermutation of Human Immunodeficiency Virus Type-1 Is Typically a Discrete All or Nothing Phenomenon
Andrew E. Armitage et al.
PLOS GENETICS (2012)
A Therapeutic Dendritic Cell-Based Vaccine for HIV-1 Infection
Felipe Garcia et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
Scott G. Hansen et al.
NATURE (2011)
Interleukin-21 administration to rhesus macaques chronically infected with simian immunodeficiency virus increases cytotoxic effector molecules in T cells and NK cells and enhances B cell function without increasing immune activation or viral replication
Suresh Pallikkuth et al.
VACCINE (2011)
The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation
Florencia Pereyra et al.
SCIENCE (2010)
Safety and immunologic effects of IL-15 administration in nonhuman primates
Carolina Berger et al.
BLOOD (2009)
Rapid Up-Regulation and Granule-Independent Transport of Perforin to the Immunological Synapse Define a Novel Mechanism of Antigen-Specific CD8+ T Cell Cytotoxic Activity
George Makedonas et al.
JOURNAL OF IMMUNOLOGY (2009)
Novel Human Interleukin-15 Agonists
Xiaoyun Zhu et al.
JOURNAL OF IMMUNOLOGY (2009)
Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys
Jinyan Liu et al.
NATURE (2009)
Lentiviral vectors encoding human immunodeficiency virus type I (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory activity
Aviva Joseph et al.
JOURNAL OF VIROLOGY (2008)
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis
M. Juliana McElrath et al.
LANCET (2008)
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
Susan P. Buchbinder et al.
LANCET (2008)
Medical progress: The challenge of HIV-1 subtype diversity
Barbara S. Taylor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover
Jorge R. Almeida et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
A whole-genome association study of major determinants for host control of HIV-1
Jacques Fellay et al.
SCIENCE (2007)
Differential effects of IL-21 and IL-15 on perforin expression, lysosomal degranulation, and proliferation in CD8 T cells of patients with human immunodeficiency virus-1 (HIV)
Lesley White et al.
BLOOD (2007)
Extensive intrasubtype recombination in South African human immunodeficiency virus type I subtype C infections
Christine M. Rousseau et al.
JOURNAL OF VIROLOGY (2007)
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
Asier Saez-Cirion et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells
Matthew A. Williams et al.
NATURE (2006)
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
Michael R. Betts et al.
BLOOD (2006)
Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239
Nancy A. Wilson et al.
JOURNAL OF VIROLOGY (2006)
NF-κB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation
SA Williams et al.
EMBO JOURNAL (2006)
DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge
M Rosati et al.
JOURNAL OF VIROLOGY (2005)
Transregulation of memory CD8 T-cell proliferation by IL-15Rα+ bone marrow-derived cells
KS Schluns et al.
BLOOD (2004)
Coordinate expression and trans presentation of interleukin (IL)-15Rα and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis
PR Burkett et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
JD Siliciano et al.
NATURE MEDICINE (2003)
Determinants of HIV-specific CD8 T-cell responses in HIV-infected pediatric patients and enhancement of HIV-gag-specific responses with exogenous IL-15
V Chitnis et al.
CLINICAL IMMUNOLOGY (2003)
Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity
S Oh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates
TJ Fry et al.
BLOOD (2003)
IL-15 enhances survival and function of HIV-specific CD8+ T cells
YM Mueller et al.
BLOOD (2003)
HIV-1 Nef downregulates MHC-I by a PACS-1-and PI3K-regulated ARF6 endocytic pathway
AD Blagoveshchenskaya et al.
CELL (2002)
Human immunodeficiency virus type 1 recombination: Rate, fidelity, and putative hot spots
JL Zhuang et al.
JOURNAL OF VIROLOGY (2002)
HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors
SA Migueles et al.
NATURE IMMUNOLOGY (2002)
Mutational analysis of HIV-1 long terminal repeats to explore the relative contribution of reverse transcriptase and RNA polymerase II to viral mutagenesis
PK O'Neil et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure
CT Ruff et al.
JOURNAL OF VIROLOGY (2002)
Cytokine requirements for acute and basal homeostatic proliferation of naive and memory CD8+ T cells
AW Goldrath et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
JW Shiver et al.
NATURE (2002)
Dynamic polarization of the microtubule cytoskeleton during CTL-Mediated killing
JR Kuhn et al.
IMMUNITY (2002)
Macrophages present exogenous antigens by class I major histocompatibility complex molecules via a secretory pathway as a consequence of interferon-γ activation
N Martín-Orozco et al.
IMMUNOLOGY (2001)
From transcription to cell surface expression, the induction of MHC class III-Aα by interferon-γ in macrophages is regulated at different levels
M Cullell-Young et al.
IMMUNOGENETICS (2001)
Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo
KS Schluns et al.
NATURE IMMUNOLOGY (2000)
HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors
SA Migueles et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)